4//SEC Filing
Strapps Walter 4
Accession 0001213900-21-013236
CIK 0001816736other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:37 PM ET
Size
5.7 KB
Accession
0001213900-21-013236
Insider Transaction Report
Form 4
Strapps Walter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+99,133→ 99,133 totalExercise: $15.60Exp: 2031-02-28→ Common Stock (99,133 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 1, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001849041
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:37 PM ET
- Size
- 5.7 KB